SCHEMBL22033249

SCHEMBL22033249

CC(C)c1cccc(NC(=O)c2cc(N3CCCS3(O)O)ccc2Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FADS1 O60427 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ KMT2A Q03164 5/20 0.42
▸ MEN1 O00255 4/20 0.42
▸ HTT P42858 2/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ RPS6KA2 Q15349 1/20 0.42
▸ TP53 P04637 3/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ KIF18A Q8NI77 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ G6PD P11413 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ CCR6 P51684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22033250 0.90 TP53 (0.53) FADS1RXFP1SMN1; SMN2KMT2AMEN1
SCHEMBL22033048 0.87 MEN1 (0.51) FADS1SMN1; SMN2KMT2AMEN1HTT
SCHEMBL22033380 0.86 ACKR3 (0.41) SMN1; SMN2KMT2AMEN1HTTCYP1A2
SCHEMBL22032946 0.85 KMT2A (0.51) SMN1; SMN2KMT2AMEN1HTTCYP1A2
SCHEMBL22033357 0.84 TP53 (0.47) RXFP1SMN1; SMN2KMT2AMEN1HTT
SCHEMBL22033673 0.84 MEN1 (0.48) SMN1; SMN2KMT2AMEN1HTTCYP1A2
SCHEMBL22032868 0.84 MEN1 (0.53) FADS1SMN1; SMN2KMT2AMEN1HTT
SCHEMBL22033379 0.83 RXFP1 (0.53) RXFP1SMN1; SMN2KMT2AMEN1HTT
SCHEMBL22033502 0.83 SMN1; SMN2 (0.43) SMN1; SMN2KMT2AMEN1HTTCYP1A2
SCHEMBL22032864 0.81 KMT2A (0.46) SMN1; SMN2KMT2AMEN1HTTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020117877-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE AQUINNAH PHARMACEUTICALS, INC. (US) 2020-06-11 — — WO disclosed
Send feedback